Dan Lindholm Selected Research

Dan Lindholm Research Topics

Disease

7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 04/2004
5	Brain Injuries (Brain Injury) 03/2021 - 12/2007
5	Huntington Disease (Huntington's Disease) 12/2019 - 03/2008
4	Neoplasms (Cancer) 01/2022 - 10/2004
4	Neuroblastoma 01/2017 - 11/2002
4	Nervous System Diseases (Neurological Disorders) 04/2016 - 01/2007
4	Ischemia 10/2011 - 06/2003
3	Stroke (Strokes) 03/2021 - 09/2004
3	Brain Diseases (Brain Disorder) 11/2014 - 01/2013
3	Epilepsy (Aura) 10/2011 - 10/2003
3	Seizures (Absence Seizure) 01/2007 - 01/2002
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2007 - 10/2003
2	Infarction (Infarctions) 03/2021 - 06/2004
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 03/2018 - 11/2002
2	Inflammation (Inflammations) 05/2016 - 11/2002
2	Neuroinflammatory Diseases 04/2016 - 03/2014
2	Parkinson Disease (Parkinson's Disease) 04/2016 - 04/2012
2	Leukemia 01/2016 - 09/2007
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016 - 01/2010
2	Wounds and Injuries (Trauma) 12/2007 - 04/2004
2	Hypoxia (Hypoxemia) 12/2007 - 06/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2022
1	Heart Diseases (Heart Disease) 02/2022
1	Infections 02/2022
1	Poliomyelitis (Polio) 02/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Ischemic Stroke 03/2021
1	COVID-19 01/2021
1	Fatty Liver 11/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Cataplexy 03/2018
1	Narcolepsy 03/2018
1	Dementia (Dementias) 01/2016
1	Neurodevelopmental Disorders 10/2013
1	Tuberous Sclerosis (Bourneville's Disease) 01/2012
1	Encephalitis (Encephalitis, Rasmussen) 06/2010
1	Immune System Diseases (Immune Disorders) 06/2010
1	Osteosarcoma (Osteogenic Sarcoma) 02/2008

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 02/2022 - 11/2002
5	Glutamic Acid (Glutamate)FDA Link 01/2016 - 10/2003
4	Pharmaceutical PreparationsIBA 01/2022 - 04/2004
3	Nerve Growth Factor (NGF)IBA 11/2019 - 11/2002
3	X-Linked Inhibitor of Apoptosis ProteinIBA 03/2016 - 06/2004
2	LipidsIBA 01/2019 - 05/2016
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 01/2016
2	AntibodiesIBA 03/2018 - 07/2006
2	Neuroprotective AgentsIBA 01/2016 - 04/2012
2	UbiquitinIBA 11/2014 - 04/2004
2	StaurosporineIBA 02/2008 - 03/2003
2	AntioxidantsIBA 12/2007 - 12/2007
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2007 - 12/2005
2	Kainic Acid (Kainate)IBA 01/2007 - 01/2002
2	Messenger RNA (mRNA)IBA 12/2003 - 01/2002
1	EpitopesIBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	CholesterolIBA 01/2022
1	lenvatinibIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Simvastatin (Zocor)FDA LinkGeneric 01/2022
1	ChloridesIBA 03/2021
1	Ethanol (Ethyl Alcohol)IBA 03/2021
1	Apoptosis Regulatory ProteinsIBA 03/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	SphingolipidsIBA 01/2021
1	Prolyl OligopeptidasesIBA 12/2019
1	polyglutamineIBA 12/2019
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 11/2019
1	Nerve Growth Factors (Neurotrophins)IBA 11/2019
1	AntigensIBA 03/2018
1	prostaglandin D2 receptorIBA 03/2018
1	VaccinesIBA 03/2018
1	Peptides (Polypeptides)IBA 03/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2018
1	OrexinsIBA 03/2018
1	pandemrixIBA 03/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Orexin ReceptorsIBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2016
1	NeuropeptidesIBA 04/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2016
1	Dopamine (Intropin)FDA LinkGeneric 04/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Huntingtin ProteinIBA 11/2014
1	Deubiquitinating EnzymesIBA 11/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2013
1	Sirtuin 1IBA 04/2012
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2012
1	ResveratrolIBA 02/2012
1	trans-sodium crocetinate (crocetin)IBA 01/2012
1	CyclinsIBA 10/2011
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 06/2010
1	Inhibitor of Apoptosis ProteinsIBA 12/2007
1	3-nitrotyrosineIBA 12/2007

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2013